Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies

Cited by (481)

Items 201–300 of 481

1. Patient-derived models facilitate precision medicine in liver cancer by remodeling cell-matrix interaction
   Kaiwen Chen, Yanran Li, Bingran Wang, Xuehan Yan, Yiying Tao, Weizhou Song, Zhifeng Xi, Kang He, Qiang Xia · 2023 · Frontiers in Immunology
2. Identification of cancer-related gene network in hepatocellular carcinoma by combined bioinformatic approach and experimental validation
   Wenkai Ni, Shiqing Zhang, Bo Jiang, Runzhou Ni, Mingbing Xiao, Cuihua Lu, Jinxia Liu, Lishuai Qu, Hongbing Ni, Wenwen Zhang et al. · 2019 · Pathology - Research and Practice
3. Generation of liver bipotential organoids with a small-molecule cocktail
   Xin Wang, Chao Ni, Ning Jiang, Jinsong Wei, Jianqing Liang, Bing Tian Zhao, Xinhua Lin · 2020 · Journal of Molecular Cell Biology
4. Organoids: Principle, application and perspective
   Kaizheng Liu, Xinyi Fang, Abdellah Aazmi, Qingzhe Wang, Xiaofeng Gong, Zhengkun Chen, Minghao Qin, Chunyi Pu, Ying Zhao, Xiaozhong Qiu et al. · 2024 · The Innovation Life
5. Engineering Heterogeneous Tumor Models for Biomedical Applications
   Zhuhao Wu, Danqing Huang, Jinglin Wang, Yuanjin Zhao, Weijian Sun, Xian Shen · 2023 · Advanced Science
6. Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches
   Razia Zakarya, Viive Maarika Howell, Emily K. Colvin · 2020 · International Journal of Molecular Sciences
7. Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers
   Masahiro Shiihara, Tomohiko Ishikawa, Yuriko Saiki, Yuko Omori, Katsuya Hirose, Shinichi Fukushige, Naoki Ikari, Ryota Higuchi, Masakazu Yamamoto, Takanori Morikawa et al. · 2021 · European Journal of Cancer
8. Advances in liver organoids: model systems for liver disease
   Jaeseo Lee, Seon Ju Mun, Yongbo Shin, Seonbhin Lee, Myung Jin Son · 2022 · Archives of Pharmacal Research
9. Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies
   Michael E. Lidsky, Zechen Wang, Min Lu, Annie Liu, David S. Hsu, Shannon J. McCall, Zhecheng Sheng, Joshua A. Granek, Kouros Owzar, Karen S. Anderson et al. · 2022 · npj Precision Oncology
10. Organoid models: the future companions of personalized drug development
    Francesco Piraino, Mariana Costa, Marine Meyer, Georgina H. Cornish, Camilla Ceroni, Virginie Garnier, Sylke Hoehnel, Nathalie Brandenberg · 2024 · Biofabrication
11. Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid
    Zhiwei Wang, Yun Jin, Yinghao Guo, Zhenhua Tan, Xiaoxiao Zhang, Dan Ye, Yuanquan Yu, Shu-you Peng, Lei Zheng, Jiangtao Li · 2021 · Cancers
12. Living Biobanks of Organoids: Valuable Resource for Translational Research
    Wenqing Huang, Zhaoting Xu, Shuang Li, Junmei Zhou, Bing Tian Zhao · 2024 · Biopreservation and Biobanking
13. Efficacy and safety of first-line treatments for advanced hepatocellular carcinoma patients: a systematic review and network meta-analysis
    Jingyi Li, Bowen Yang, Zan Teng, Yunpeng Liu, Danni Li, Xiujuan Qu · 2024 · Frontiers in Immunology
14. Application of Patient-Derived Cancer Organoids to Personalized Medicine
    Masahiro Shiihara, Toru Furukawa · 2022 · Journal of Personalized Medicine
15. Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma
    Dokyeong Kim, Junseong Park, Hyeon‐Chun Park, Songzi Zhang, Minyoung Park, Soon A Park, Sug Hyung Lee, Youn Soo Lee, Jae‐Sung Park, Sin‐Soo Jeun et al. · 2024 · Cancer Cell International
16. Liver organoids: From fabrication to application in liver diseases
    Qianglin Liu, Anqi Zeng, Zibo Liu, Chunjie Wu, Linjiang Song · 2022 · Frontiers in Physiology
17. DMLDA-LocLIFT: Identification of multi-label protein subcellular localization using DMLDA dimensionality reduction and LIFT classifier
    Qi Zhang, Shan Li, Bin Yu, Qingmei Zhang, Yu Han, Yan Zhang, Qin Ma · 2020 · Chemometrics and Intelligent Laboratory Systems
18. Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
    Qiu-Shi Feng, Xiaofeng Shan, Vicky Yau, Zhigang Cai, Shang Xie · 2025 · Pharmaceuticals
19. Head and neck tumor organoid biobank for modelling individual responses to radiation therapy according to the TP53/HPV status
    Christian Issing, Constantin Menche, Mara Romero Richter, Mohammed H. Mosa, Jens von der Grün, Maximilian Fleischmann, Philipp Thoenissen, Ria Winkelmann, Tahmineh Darvishi, Andreas German Loth et al. · 2025 · Journal of Experimental & Clinical Cancer Research
20. Advancing hepatotoxicity assessment: current advances and future directions
    Yewon Kim, Yohan Kim, Yohan Kim · 2025 · Toxicological Research
21. Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization
    Tuyana Boldanova, Geoffrey Fucile, Jan Vosshenrich, Aleksei Suslov, Caner Ercan, Mairene Coto‐Llerena, Luigi Terracciano, Christoph Johannes Zech, Daniel Tobias Boll, Stefan F. Wieland et al. · 2021 · Cell Reports Medicine
22. Organoids as research models for hepatocellular carcinoma
    Justin HY. Yu, Stephanie Ma · 2021 · Experimental Cell Research
23. Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma.
    Mairene Coto‐Llerena, Andrej Benjak, John Gallon, Marie‐Anne Meier, Tuyana Boldanova, Luigi Terracciano, Charlotte K.Y. Ng, Salvatore Piscuoglio · 2022
24. Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma
    Sunisa Prasopporn, Orawan Suppramote, Ben Ponvilawan, Chanettee Jamyuang, Jantappapa Chanthercrob, Amphun Chaiboonchoe, Pimkanya More-Krong, Kamonchanok Kongsri, Monthira Suntiparpluacha, Rawisak Chanwat et al. · 2022 · Frontiers in Oncology
25. Spheroid on-demand printing and drug screening of endothelialized hepatocellular carcinoma model at different stages
    Tiankun Liu, Chang Zhou, Jingyuan Ji, Xiaolei Xu, Zhengyu Xing, Marie Shinohara, Yasuyuki Sakai, Taoping Sun, Xiaobin Feng, Zhuo Yu et al. · 2023 · Biofabrication
26. Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma
    Xiao-chang Fang, Lin Shu, TianLiang Chen, XiaoLe Zhao, LiuCui Yang, Tingting Dou, Lijie Yang, Xuanfei Li, Maohui Feng · 2024 · Molecular Cancer
27. Research progress and application of liver organoids for disease modeling and regenerative therapy
    Yang Hu, Qiao Geng, L. Wang, Yi Wang, Chuyue Huang, Zhimin Fan, Desong Kong · 2024 · Journal of Molecular Medicine
28. Hepatocellular-Carcinoma-Derived Organoids: Innovation in Cancer Research
    Carlo Airola, Maria Pallozzi, Eleonora Cesari, Lucia Cerrito, Leonardo Stella, Claudio Sette, Felice Giuliante, Antonio Gasbarrini, Francesca Romana Ponziani · 2024 · Cells
29. Organoid Models for Cancer Research—From Bed to Bench Side and Back
    Carolin Kastner, Anne Hendricks, Hanna Deinlein, Mohammed K. Hankir, Christoph‐Thomas Germer, Stefanie Schmidt, Armin Wiegering · 2021 · Cancers
30. From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players
    Avilene Rodríguez‐Lara, Ascensión Rueda‐Robles, María José Sáez‐Lara, Julio Plaza‐Díaz, Ana I. Álvarez‐Mercado · 2023 · Pathogens
31. 3D Models of Sarcomas: The Next-generation Tool for Personalized Medicine
    Ruiling Xu, Ruiqi Chen, Chao Tu, X.Y. Gong, Zhongyue Liu, Lin Mei, Xiaolei Ren, Zhihong Li · 2023 · Phenomics
32. Ultra-small tissue-compatible organoid printer for rapid and controllable modeling of respiratory organoids
    Haowei Yang, Jiawei Li, Y.K. Zheng, Yuanxiong Cao, Yu Zhu, Gan Sang, Edgar A. Galan, Chuqian Ruan, Winson M.J. Ma, Xiaoyong Dai et al. · 2024 · Device
33. Nanoplasmonic Single‐Tumoroid Microarray for Real‐Time Secretion Analysis
    Yen‐Cheng Liu, Saeid Ansaryan, Jiayi Tan, Nicolas Broguière, Luis Francisco Lorenzo‐Martín, Krisztián Homicskó, George Coukos, Matthias P. Lütolf, Hatice Altug · 2024 · Advanced Science
34. Stratifying nutritional restriction in cancer therapy: Next stop, personalized medicine
    Jelena Krstić, Thomas Rudolf Pieber, Andreas Prokesch · 2020 · International review of cytology
35. The application of organoids in treatment decision-making for digestive system cancers: progress and challenges
    Yufei Wang, Limin Zhang, Louis Zizhao Wang, Yang Cao, Lulu Huang, Gautam Sethi, Xiaoguang Chen, Lingzhi Wang, Boon Cher Goh · 2025 · Molecular Cancer
36. Iteration of Tumor Organoids in Drug Development: Simplification and Integration
    Rui Zhao, Qiushi Feng, Yangyang Xia, Lingzi Liao, Shang Xie · 2025 · Pharmaceuticals
37. Organoid research: new concepts and new technologies
    Jin Zhang, Yuezhou Wu, Tianzhuo Shen, Yingrui Mao, Hongjing Dou, Yi Lin, Zhen Geng, Zhanghua Li, Jiacan Su · 2026 · Burns & Trauma
38. Patient-derived organoids as a model for tumor research
    Jia Wang, Xiaoying Feng, Zhichao Li, Yongsong Chen, Weiren Huang · 2022 · Progress in molecular biology and translational science
39. Tumor Organoids as a Research Tool: How to Exploit Them
    Tijmen H. Booij, Chiara M. Cattaneo, Christian Hirt · 2022 · Cells
40. Bioengineered Organoids Offer New Possibilities for Liver Cancer Studies: A Review of Key Milestones and Challenges
    Abdullah Jabri, Jibran Ahmad Khan, Bader Taftafa, Mohamed Alsharif, Abdulaziz Mhannayeh, Raja Chinnappan, Alaa Alzhrani, Shadab Kazmi, Mohammad Shabab Mir, Aljohara Waleed Alsaud et al. · 2024 · Bioengineering
41. Tumor organoids for primary liver cancers: A systematic review of current applications in diagnostics, disease modeling, and drug screening
    Ayesha A. Qureshi, Chase J. Wehrle, Sofía Ferreira-González, Chunbao Jiao, Hanna Hong, Neda Dadgar, Jorge E. Arpi-Palacios, Yee Phoon Phong, JaeKeun Kim, Keyue Sun et al. · 2024 · JHEP Reports
42. Organoid culture to study epithelial cell differentiation and barrier formation in the colon: bridging the gap between monolayer cell culture and human subject research
    James Varani, Shannon D. McClintock, Muhammad N. Aslam · 2021 · In Vitro Cellular & Developmental Biology - Animal
43. Label-Free Imaging Analysis of Patient-Derived Cholangiocarcinoma Organoids after Sorafenib Treatment
    Michael Koch, Sandra Nickel, Ruby Lieshout, Susanna M. Lissek, Martina Leskova, Luc J. W. van der Laan, Monique M. A. Verstegen, Bruno Christ, Francesco Pampaloni · 2022 · Cells
44. Multicellular Modelling of Difficult-to-Treat Gastrointestinal Cancers: Current Possibilities and Challenges
    Sarah K. Hakuno, Ellis Michiels, Eleonore B Kuhlemaijer, Ilse Rooman, Lukas J.A.C. Hawinkels, Marije Slingerland · 2022 · International Journal of Molecular Sciences
45. Droplet-engineered organoids recapitulate parental tissue transcriptome with inter-organoid homogeneity and inter-tumor cell heterogeneity
    Haoran Zhao, Yifan Cheng, Jiawei Li, Jiaqi Zhou, Haowei Yang, Yu Feng, Feihong Yu, Davit Khutsishvili, Zitian Wang, Shengwei Jiang et al. · 2022 · Fundamental Research
46. Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line derived from a Chinese patient
    Xin Miao, Jinjing Hu, Changpeng Chai, Huan Tang, Zhenjie Zhao, Wei Luo, Wence Zhou, Hao Xu · 2022 · Cancer Cell International
47. Overview of Tissue Engineering Concepts and Applications
    Sarah Miho Van Belleghem, Bhushan P. Mahadik, Kirstie Lane Snodderly, John P. Fisher · 2020 · Elsevier eBooks
48. The Anti-Tumor Effect of Nab-Paclitaxel Proven by Patient-Derived Organoids
    Xing Xiao, Wei Chen, Zhe-Wei Wei, Weiwei Chu, Xiaofang Lu, Bo Li, Hong Chen, Sijun Meng, Tengfei Hao, Jitao Wei et al. · 2020 · OncoTargets and Therapy
49. Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma
    John Gallon, Mairene Coto‐Llerena, Caner Ercan, Gaia Bianco, Viola Paradiso, Sandro Nuciforo, Stephanie Taha‐Mehlitz, Marie‐Anne Meier, Tuyana Boldanova, Sofía Pérez‐del‐Pulgar et al. · 2021 · Molecular Oncology
50. Instructive Hydrogels for Primary Tumor Cell Culture: Current Status and Outlook
    Yiyang Jia, Zhentong Wei, Songling Zhang, Bai Yang, Yunfeng Li · 2022 · Advanced Healthcare Materials
51. New fully automatic approach for tissue identification in histopathological examinations using transfer learning
    Yongzhao Xu, Matheus A. dos Santos, Luís Fabrício de Freitas Souza, Adriell Gomes Marques, Lijuan Zhang, José Jerovane da Costa Nascimento, Victor Hugo C. de Albuquerque, Pedro P. Rebouças Filho · 2022 · IET Image Processing
52. Remodelling and Improvements in Organoid Technology to Study Liver Carcinogenesis in a Dish
    Umesh Tharehalli, Michael Svinarenko, André Lechel · 2019 · Stem Cells International
53. Tumor in 3D: In Vitro Complex Cellular Models to Improve Nanodrugs Cancer Therapy
    Soraia Fernandes, Marco Cassani, Stefania Pagliari, Petr Filipenský, Francesca Cavalieri, Giancarlo Forte · 2020 · Current Medicinal Chemistry
54. Organoids as an Enabler of Precision Immuno-Oncology
    Junzhe Zhao, Antoinette Shui Wen Fong, See Voon Seow, Han Chong Toh · 2023 · Cells
55. Can Organoid Model Reveal a Key Role of Extracellular Vesicles in Tumors? A Comprehensive Review of the Literature
    Yang Zhang, Anqing Lu, Zixuan Zhuang, Su Zhang, Sicheng Liu, Hai‐Ning Chen, Xuyang Yang, Ziqiang Wang · 2023 · International Journal of Nanomedicine
56. Advancements and application prospects of three-dimensional models for primary liver cancer: a comprehensive review
    Liuyang Zhu, Chuanliang Cheng, Sen Liu, Long Yang, Pinsheng Han, Tao Cui, Yamin Zhang · 2023 · Frontiers in Bioengineering and Biotechnology
57. Progress, application and challenges of liver organoids
    Chen Sang, Jian Lin, Shuyi Ji, Qiang Gao · 2024 · Clinical Cancer Bulletin
58. Tumor organoids in cancer medicine: from model systems to natural compound screening
    Rong Cong, Can Lu, Xinying Li, Zhijie Xu, Yaqin Wang, Shusen Sun · 2025 · Pharmaceutical Biology
59. Application and research progress of organoids in cholangiocarcinoma and gallbladder carcinoma.
    Yun-peng Huang, Kai Liu, Yongxiang Wang, Yang Yang, Li Xiong, Zijian Zhang, Yu Wen · 2021 · PubMed Central
60. Future Match Making: When Pediatric Oncology Meets Organoid Technology
    Virginie Barbet, Laura Broutier · 2021 · Frontiers in Cell and Developmental Biology
61. Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification
    Ruby Lieshout, Alessandra Valéria de Sousa Faria, Maikel Petrus Peppelenbosch, Luc J. W. van der Laan, Monique M. A. Verstegen, Gwenny Manel Fuhler · 2022 · Molecular Medicine
62. Patient-derived xenografts and organoids model therapy response in prostate cancer
    Sofia Karkampouna, Federico La Manna, Maria Rosaria De Filippo, Mirjam Kiener, Marta De Menna, Eugenio Zoni, Joël Grosjean, Irena Klima, Andrea Garofoli, Marco Bolis et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
63. Liver cancer rapid-testing POC low-cost diagnostic unit using novel dual-gate source-extended TFET based biosensor
    Anirban Kolay, Amitesh Kumar · 2024 · Sensors and Actuators A Physical
64. Gastrointestinal Cancer Patient Derived Organoids at the Frontier of Personalized Medicine and Drug Screening
    Zhenjie Yang, Jun Qing Yu, Chi Chun Wong · 2024 · Cells
65. Patient-derived model systems and the development of next-generation anticancer therapeutics
    Nikolaus Krall, Giulio Superti‐Furga, Gregory Ian Vladimer · 2020 · Current Opinion in Chemical Biology
66. Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment
    Jiaxin Zhang, Huiqiong Han, Lei Wang, Wenjia Wang, Mei Yang, Yanru Qin · 2022 · Frontiers in Oncology
67. Flow enhances phenotypic and maturation of adult rat liver organoids
    Da Jung Jung, Jae Hee Byeon, Gi Seok Jeong · 2020 · Biofabrication
68. Cancer patient-derived organoids: Novel models for the study of natural products
    Shuxin Liu, Renyun Zhang, Yachen Liu, Xian Lin, Jian Chen · 2025 · International Journal of Biological Sciences
69. Human patient derived organoids: an emerging precision medicine model for gastrointestinal cancer research
    Sicheng Yan, Yuxuan He, Yuehong Zhu, Wangfang Ye, Yan Chen, Cong Zhu, Fuyuan Zhan, Zhihong Ma · 2024 · Frontiers in Cell and Developmental Biology
70. Current trends and research topics regarding organoids: A bibliometric analysis of global research from 2000 to 2023
    Yantong Wan, Jianan Ding, Zixuan Jia, Yinghao Hong, Guijie Tian, Shuqian Zheng, Pinfei Pan, Jieyan Wang, Hui Liang · 2024 · Heliyon
71. Exploring tumor organoids for cancer treatment
    Hairong Jin, Qian Yang, Jing Yang, Fangyan Wang, Jiayin Feng, Lanjie Lei, Minghai Dai · 2024 · APL Materials
72. Patient-derived organoids inform pharmacogenomic vulnerabilities in liver cancer
    A. M. Wong, Hao Huang, A. M. Wong, H. H. Leung, Winnie Cheung, Y. Lam, Xiaofan Ding, Luyao Zhang, Clarice Chu, Yue Liu et al. · 2025 · JHEP Reports
73. Establishment and characterization of organoids from a patient with adenomyoepithelioma of the breast
    Xiangrong Luo, Jiantao She, Tao Xu, Yuan Zhou, Chuanbo Xu, Jianping Jiang, TianGang Li, Huajiang Liu, Hui Shen, Bolong Yin et al. · 2021 · Bioengineered
74. Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening
    Cuiying Xie, Ancheng Gu, Muhammad Noman Khan, Xiangcao Yao, Leping Chen, Jiali He, Fumiao Yuan, Ping Wang, Yufan Yang, Yerong Wei et al. · 2023 · Frontiers in Oncology
75. Mini-organs with big impact: Organoids in liver cancer studies
    Muhammad Babar Khawar, YAJUN WANG, ANEEQA MAJEED, ALI AFZAL, Kabeer Haneef, Haibo Sun · 2023 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
76. Inhibition of the transmembrane transporter ABCB1 overcomes resistance to doxorubicin in patient-derived organoid models of HCC
    Lauriane Blukacz, Sandro Nuciforo, Geoffrey Fucile, Fredrik Trulsson, Urs Duthaler, Stefan F. Wieland, Markus Hermann Heim · 2024 · Hepatology Communications
77. Liver organoids: From 3D printing to biomedical applications
    Ying Shi, Xin Han, Zheng Zhang, Jiangtao Xu, Guozhen Liu · 2024 · BMEMat
78. Advances, challenges and future applications of liver organoids in experimental regenerative medicine
    Da Gong, Jiaye Mo, Mei Zhai, Fulin Zhou, Guo‐Cai Wang, Shaohua Ma, Xiaoyong Dai, Xuesong Deng · 2025 · Frontiers in Medicine
79. Organoid technologies in antitumor drug screening: past development, present applications, and future prospects
    Junfa Yang, Yipin Yang, Pengkai Xu, Yong Yao, Heng Tian, Xinyi Wang, Hui Fang, Shangqing Ge, Yan Yao, Yafen Wang et al. · 2025 · International Journal of Surgery
80. Applications and challenges of patient-derived organoids in hepatobiliary and pancreatic cancers
    Jia-Wei Hu, Yanzhi Pan, Xiaoxiao Zhang, Jiangtao Li, Yun Jin · 2025 · World Journal of Gastroenterology
81. Complex in vitro 3D models of digestive system tumors to advance precision medicine and drug testing: Progress, challenges, and trends
    Shenglei Song, Bo Li, Mariana R. Carvalho, Huijun Wang, Deli Mao, Jitao Wei, Wei Chen, Zhi-Hui Weng, Yangchao Chen, Chu‐Xia Deng et al. · 2022 · Pharmacology & Therapeutics
82. Liver organoids and their application in liver cancer research
    Xinyu Song, Kaifei Hou, Hongyan Zhou, Jingyi Yang, Ting Cao, Jiayu Zhang · 2023 · Regenerative Therapy
83. RETRACTED ARTICLE: Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer
    Haiyong Zhang, Jing Wu, Jinqiu Yuan, Huafu Li, Yawei Zhang, Wu Wang, Wei Chen, Chunming Wang, Sijun Meng, Songyao Chen et al. · 2021 · Journal of Experimental & Clinical Cancer Research · Retracted
84. Next-Generation Modeling of Cancer Using Organoids
    Jillian R Love, Wouter R. Karthaus · 2023 · Cold Spring Harbor Perspectives in Medicine
85. An original donor-dependent spheroid system for the prediction of idiosyncratic drug-induced liver injury risk
    Sara Cherradi, Nicolas Taulet, Hong Tuan Duong · 2023 · In vitro models
86. Exploring in vitro modeling in hepatocarcinogenesis research: morphological and molecular features and similarities to the corresponding human disease
    Letícia Cardoso Valente, Gabriel Prata Bacil, Luana Riechelmann-Casarin, Giullia Cavichiolli Barbosa, Luı́s Fernando Barbisan, Guilherme Ribeiro Romualdo · 2024 · Life Sciences
87. Mesenchymal stromal cells promote the formation of lung cancer organoids via Kindlin-2
    Zhilin Sui, Xianxian Wu, Jiaxin Wang, ShihJye Tan, Chao Zhao, Zhentao Yu, Chuanyue Wu, Xiaoxiao Wang, Ling Guo · 2025 · Stem Cell Research & Therapy
88. Microfabricated Organ-Specific Models of Tumor Microenvironments
    Jeong Min Oh, Yongkuk Park, Jungwoo Lee, Keyue Shen · 2025 · Annual Review of Biomedical Engineering
89. Advances towards the use of gastrointestinal tumor patient-derived organoids as a therapeutic decision-making tool
    Javiera Obreque, Luis Vergara-Gómez, Nicolás Venegas, Helga L. Weber, Gareth I. Owen, Pablo Ernesto Pérez, Pamela Leal, Juan Carlos Roa, Carolina Bizama · 2023 · Biological Research
90. Lymphotoxin beta‐activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma
    Kaiyu Xu, Annika Kessler, Federico Nichetti, Paula Hoffmeister‐Wittmann, Anna‐Lena Scherr, Luisa Nader, Eblina Kelmendi, Nathalie Schmitt, Maximilian Schwab, Maria Garcia Beccaria et al. · 2024 · Liver International
91. In vitro 3D liver tumor microenvironment models for immune cell therapy optimization
    Maxine S. Y. Lam, Jose Antonio Reales‐Calderón, Jin Rong Ow, Giulia Adriani, Andrea Pavesi · 2021 · APL Bioengineering
92. Evaluation of the tumoricidal efficacy of adoptive cell transfer using hepatocellular carcinoma-derived organoids
    Zizhen Zhou, Xiaoluan Yan, Wanwan Shi, Kangan Tan, Chen Shao, Yan Wang, Guiqiang Wang, Yuan Hong · 2022 · Journal of Gastrointestinal Oncology
93. Development and validation of deep learning for predicting the growth of ovarian cancer organoids
    Hongji Wu, Lifang Ma, Ling Wang, Xueping Zhu, Xiaogang Luo, Cong Zhang, Chunfang Ha, Yun Mi Dang, Haixia Wang, Dongling Zou · 2025 · Chinese Medical Journal
94. Liver biopsy in the modern era: from traditional techniques to artificial intelligence and multi-omics integration
    Nasar Alwahaibi, Maryam Alwahaibi · 2025 · Frontiers in Medicine
95. Protocols to culture and harvest hepatic tumor organoids for metabolic assays
    Man Tong, Stephanie Ma · 2022 · STAR Protocols
96. Comparing Long-Term survival benefits of hepatocellular carcinoma between thermal ablation monotherapy and combined therapy with transarterial Chemoembolization: A propensity score matched study
    Ke Zhang, Lei Mu, Yiyue Ren, Tianan Jiang · 2023 · European Journal of Radiology
97. A Novel Liver Cancer POC Diagnostic Detection Technique by a Gate-engineered Source-extended TFET Device
    Anirban Kolay, Amitesh Kumar · 2024 · Medical Engineering & Physics
98. Moderate expression of CD39 in GPC3-CAR-T cells shows high efficacy against hepatocellular carcinoma
    Fan Zou, Jialiang Wei, Jialang Zhuang, Yafang Liu, Jizhou Tan, Xianzhang Huang, Ting Liu · 2024 · Frontiers of Medicine
99. Primary liver cancer organoids and their application to research and therapy
    Xiaobin Zhu, Rajiv Trehan, Changqing Xie · 2024 · Journal of the National Cancer Center
100. Development and Application of Patient-Derived Cancer Organoidsin Clinical Management of Gastrointestinal Cancer: A State-of-the-Art Review
     Ruobing Zhang, Tiantian Guo, Lulin Ji, Yirui Yin, Shuitu Feng, Weihong Lu, Fei Zhang, Maoshu Zhu, Shugang Liu, Jinhua Jiang et al. · 2021 · Frontiers in Oncology